Budillon A - Search Results

1

HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer.

Lombardi R, Sonego M, Pucci B, Addi L, Iannelli F, Capone F, Alfano L, Roca MS, Milone MR, Moccia T, Costa A, Di Gennaro E, Bruzzese F, Baldassarre G, Budillon A. Lombardi R, et al. Among authors: budillon a. Mol Oncol. 2021 Apr;15(4):1005-1023. doi: 10.1002/1878-0261.12883. Epub 2021 Jan 19. Mol Oncol. 2021. PMID: 33331136 Free PMC article.

2

8-Cl-cAMP antagonizes mitogen-activated protein kinase activation and cell growth stimulation induced by epidermal growth factor.

Budillon A, Di Gennaro E, Caraglia M, Barbarulo D, Abbruzzese A, Tagliaferri P. Budillon A, et al. Br J Cancer. 1999 Dec;81(7):1134-41. doi: 10.1038/sj.bjc.6690820. Br J Cancer. 1999. PMID: 10584873 Free PMC article.

3

Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase I-II trial of the Southern Italy Cooperative Oncology Group (SICOG).

Caponigro F, Comella P, Rivellini F, Avallone A, Budillon A, Di Gennaro E, Mozzillo N, Ionna F, De Rosa V, Manzione L, Comella G. Caponigro F, et al. Among authors: budillon a. Ann Oncol. 2000 May;11(5):575-80. doi: 10.1023/a:1008339428733. Ann Oncol. 2000. PMID: 10907951 Free article. Clinical Trial.

4

Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells.

Di Gennaro E, Barbarino M, Bruzzese F, De Lorenzo S, Caraglia M, Abbruzzese A, Avallone A, Comella P, Caponigro F, Pepe S, Budillon A. Di Gennaro E, et al. Among authors: budillon a. J Cell Physiol. 2003 Apr;195(1):139-50. doi: 10.1002/jcp.10239. J Cell Physiol. 2003. PMID: 12599217

5

Acetylation of proteins as novel target for antitumor therapy: review article.

Di Gennaro E, Bruzzese F, Caraglia M, Abruzzese A, Budillon A. Di Gennaro E, et al. Among authors: budillon a. Amino Acids. 2004 Jul;26(4):435-41. doi: 10.1007/s00726-004-0087-3. Epub 2004 Jun 11. Amino Acids. 2004. PMID: 15290351 Review.

6

Multiple-target drugs: inhibitors of heat shock protein 90 and of histone deacetylase.

Budillon A, Bruzzese F, Di Gennaro E, Caraglia M. Budillon A, et al. Curr Drug Targets. 2005 May;6(3):337-51. doi: 10.2174/1389450053765905. Curr Drug Targets. 2005. PMID: 15857292 Review.

7

Docetaxel induces p53-dependent apoptosis and synergizes with farnesyl transferase inhibitor r115777 in human epithelial cancer cells.

Caraglia M, Giuberti G, Marra M, Di Gennaro E, Facchini G, Caponigro F, Iaffaioli R, Budillon A, Abbruzzese A. Caraglia M, et al. Among authors: budillon a. Front Biosci. 2005 Sep 1;10:2566-75. doi: 10.2741/1720. Front Biosci. 2005. PMID: 15970518

8

Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-alpha in head and neck cancer cells in vitro and in vivo.

Bruzzese F, Di Gennaro E, Avallone A, Pepe S, Arra C, Caraglia M, Tagliaferri P, Budillon A. Bruzzese F, et al. Among authors: budillon a. Clin Cancer Res. 2006 Jan 15;12(2):617-25. doi: 10.1158/1078-0432.CCR-05-1671. Clin Cancer Res. 2006. PMID: 16428508

9

Synergistic antitumour effect of raltitrexed and 5-fluorouracil plus folinic acid combination in human cancer cells.

Avallone A, Di Gennaro E, Bruzzese F, Laus G, Delrio P, Caraglia M, Pepe S, Comella P, Budillon A. Avallone A, et al. Among authors: budillon a. Anticancer Drugs. 2007 Aug;18(7):781-91. doi: 10.1097/CAD.0b013e32809ef9b7. Anticancer Drugs. 2007. PMID: 17581300

10

The ribosomal P0 protein induces a spontaneous immune response in patients with head and neck advanced stage carcinoma that is not dependent on its overexpression in carcinomas.

Bei R, Masuelli L, Trono P, Orvietani PL, Losito S, Marzocchella L, Vitolo D, Albonici L, Mrozek MA, Di Gennaro E, Lista F, Faggioni G, Ionna F, Binaglia L, Manzari V, Budillon A, Modesti A. Bei R, et al. Among authors: budillon a. Int J Oncol. 2007 Dec;31(6):1301-8. Int J Oncol. 2007. PMID: 17982655

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

224 results

Search Page